Rituxan Helps in Vasculitis Over Long Term (CME/CE)

(MedPage Today) -- A single course of treatment with rituximab (Rituxan) was as effective over 18 months as conventional immunosuppression among patients with severe organ- or life-threatening vasculitis, a randomized noninferiority trial found.
Source: MedPage Today Rheumatology - Category: Rheumatology Source Type: news